Kristen Gajewski - 17 Feb 2023 Form 4 Insider Report for AVIENT CORP (AVNT)

Role: SVP & CHRO
Signature: /s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski
Issuer symbol: AVNT
Transactions as of: 17 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 21 Feb 2023, 10:42:01 UTC
Previous filing: 14 Feb 2023
Next filing: 12 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVNT	Restricted Stock Units	Award	$0	+3,450		$0.000000	3,450	17 Feb 2023	Common Stock	3,450		Direct	F1
transaction	AVNT	Stock Appreciation Rights	Award	$0	+11,600		$0.000000	11,600	17 Feb 2023	Common Stock	11,600	$42.93	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.

Content

Each restricted stock unit represents a contingent right to receive one share of Avient common stock.

SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.